25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Allakos Inc
Buy, Hold or Sell?

Let's analyze Allakos together

I guess you are interested in Allakos Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Allakos Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Allakos Inc

I send you an email if I find something interesting about Allakos Inc.

1. Quick Overview

1.1. Quick analysis of Allakos (30 sec.)










1.2. What can you expect buying and holding a share of Allakos? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.81
Expected worth in 1 year
$-0.85
How sure are you?
18.8%

+ What do you gain per year?

Total Gains per Share
$-1.66
Return On Investment
-150.9%

For what price can you sell your share?

Current Price per Share
$1.10
Expected price per share
$0.7255 - $1.72
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Allakos (5 min.)




Live pricePrice per Share (EOD)
$1.10
Intrinsic Value Per Share
$-2.79 - $-2.43
Total Value Per Share
$-1.98 - $-1.62

2.2. Growth of Allakos (5 min.)




Is Allakos growing?

Current yearPrevious yearGrowGrow %
How rich?$72.7m$266.7m-$159.3m-148.4%

How much money is Allakos making?

Current yearPrevious yearGrowGrow %
Making money-$44.6m-$40m-$4.6m-10.3%
Net Profit Margin-145.4%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Allakos (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#403 / 949

Most Revenue
#403 / 949

Most Profit
#822 / 949

Most Efficient
#489 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Allakos?

Welcome investor! Allakos's management wants to use your money to grow the business. In return you get a share of Allakos.

First you should know what it really means to hold a share of Allakos. And how you can make/lose money.

Speculation

The Price per Share of Allakos is $1.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Allakos.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Allakos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.81. Based on the TTM, the Book Value Change Per Share is $-0.41 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Allakos.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-18.7%-0.50-45.5%-0.46-42.3%-0.60-54.4%-0.42-38.6%
Usd Book Value Change Per Share-0.13-11.5%-0.41-37.7%-0.34-31.3%-0.25-22.5%0.032.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.13-11.5%-0.41-37.7%-0.34-31.3%-0.25-22.5%0.032.3%
Usd Price Per Share0.65-1.41-4.88-39.45-32.77-
Price to Earnings Ratio-0.79--0.75--2.65--20.83--23.87-
Price-to-Total Gains Ratio-5.18--4.02--14.21--89.23--104.46-
Price to Book Ratio0.80-1.10-1.57-7.10-7.77-
Price-to-Total Gains Ratio-5.18--4.02--14.21--89.23--104.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1
Number of shares909
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.41-0.25
Usd Total Gains Per Share-0.41-0.25
Gains per Quarter (909 shares)-377.21-224.69
Gains per Year (909 shares)-1,508.83-898.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1509-15190-899-909
20-3018-30280-1798-1808
30-4527-45370-2696-2707
40-6035-60460-3595-3606
50-7544-75550-4494-4505
60-9053-90640-5393-5404
70-10562-105730-6291-6303
80-12071-120820-7190-7202
90-13580-135910-8089-8101
100-15088-151000-8988-9000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.031.00.03.1%1.031.00.03.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%6.023.03.018.8%6.023.03.018.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.032.00.0%0.00.032.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%6.023.03.018.8%6.023.03.018.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Allakos Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.126-0.415+229%-0.345+173%-0.247+96%0.025-595%
Book Value Per Share--0.8141.202-32%2.985-73%3.900-79%2.851-71%
Current Ratio--6.0794.668+30%9.861-38%14.988-59%15.927-62%
Debt To Asset Ratio--0.4150.400+4%0.204+103%0.198+110%0.318+31%
Debt To Equity Ratio--0.7110.680+4%0.257+176%0.282+152%0.297+139%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--99383239.520189448450.880-48%604244550.000-84%3804032945.776-97%4016905548.301-98%
Eps---0.206-0.500+143%-0.465+126%-0.599+191%-0.425+107%
Ev To Ebitda Ratio---1.258-1.214-3%-3.477+176%-21.969+1646%-31.335+2391%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.355-0.295-17%-0.392+10%-0.482+36%-0.347-2%
Free Cash Flow To Equity Per Share---0.355-0.293-17%-0.386+9%-0.239-33%0.028-1365%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.431--------
Intrinsic Value_10Y_min---2.791--------
Intrinsic Value_1Y_max---1.848--------
Intrinsic Value_1Y_min---1.816--------
Intrinsic Value_3Y_max---4.331--------
Intrinsic Value_3Y_min---4.159--------
Intrinsic Value_5Y_max---5.338--------
Intrinsic Value_5Y_min---5.060--------
Market Cap98277960.000+41%58359239.520126045950.880-54%435550050.000-87%3524887345.776-98%2928189584.610-98%
Net Profit Margin----1.4540%-0%-0.2910%-0.1820%
Operating Margin----1.5100%-0%-0.3020%-0.1890%
Operating Ratio---1.510-100%-0%0.302-100%0.189-100%
Pb Ratio1.351+41%0.8021.098-27%1.572-49%7.102-89%7.769-90%
Pe Ratio-1.337-68%-0.794-0.750-5%-2.651+234%-20.827+2523%-23.873+2906%
Price Per Share1.100+41%0.6531.411-54%4.875-87%39.453-98%32.774-98%
Price To Free Cash Flow Ratio-0.774-68%-0.460-1.289+180%-2.986+549%-26.277+5615%-29.175+6245%
Price To Total Gains Ratio-8.731-68%-5.185-4.016-23%-14.205+174%-89.229+1621%-104.458+1915%
Quick Ratio--10.9497.788+41%14.624-25%24.673-56%24.830-56%
Return On Assets---0.148-0.244+65%-0.122-17%-0.153+3%-0.190+29%
Return On Equity---0.253-0.406+61%-0.154-39%-0.210-17%-0.280+11%
Total Gains Per Share---0.126-0.415+229%-0.345+173%-0.247+96%0.025-595%
Usd Book Value--72743000.000107385500.000-32%266725500.000-73%348467600.000-79%254759437.500-71%
Usd Book Value Change Per Share---0.126-0.415+229%-0.345+173%-0.247+96%0.025-595%
Usd Book Value Per Share--0.8141.202-32%2.985-73%3.900-79%2.851-71%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--99383239.520189448450.880-48%604244550.000-84%3804032945.776-97%4016905548.301-98%
Usd Eps---0.206-0.500+143%-0.465+126%-0.599+191%-0.425+107%
Usd Free Cash Flow---31731000.000-26368249.750-17%-34978750.000+10%-43071399.950+36%-31002031.219-2%
Usd Free Cash Flow Per Share---0.355-0.295-17%-0.392+10%-0.482+36%-0.347-2%
Usd Free Cash Flow To Equity Per Share---0.355-0.293-17%-0.386+9%-0.239-33%0.028-1365%
Usd Market Cap98277960.000+41%58359239.520126045950.880-54%435550050.000-87%3524887345.776-98%2928189584.610-98%
Usd Price Per Share1.100+41%0.6531.411-54%4.875-87%39.453-98%32.774-98%
Usd Profit---18372000.000-44686250.000+143%-40067500.000+118%-53140700.000+189%-37739906.250+105%
Usd Revenue---2689000.000-100%-0%537800.000-100%336125.000-100%
Usd Total Gains Per Share---0.126-0.415+229%-0.345+173%-0.247+96%0.025-595%
 EOD+5 -3MRQTTM+15 -19YOY+16 -165Y+16 -1810Y+10 -24

3.3 Fundamental Score

Let's check the fundamental score of Allakos Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.337
Price to Book Ratio (EOD)Between0-11.351
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.949
Current Ratio (MRQ)Greater than16.079
Debt to Asset Ratio (MRQ)Less than10.415
Debt to Equity Ratio (MRQ)Less than10.711
Return on Equity (MRQ)Greater than0.15-0.253
Return on Assets (MRQ)Greater than0.05-0.148
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Allakos Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.475
Ma 20Greater thanMa 501.112
Ma 50Greater thanMa 1000.987
Ma 100Greater thanMa 2000.848
OpenGreater thanClose1.100
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Allakos Inc

Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.

Fundamental data was last updated by Penke on 2024-12-05 11:59:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Allakos earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Allakos Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-145.4%+145.4%
TTM-145.4%YOY--145.4%
TTM-145.4%5Y-29.1%-116.3%
5Y-29.1%10Y-18.2%-10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.0%+108.0%
TTM-145.4%-218.6%+73.2%
YOY--210.1%+210.1%
5Y-29.1%-339.1%+310.0%
10Y-18.2%-464.5%+446.3%
4.3.1.2. Return on Assets

Shows how efficient Allakos is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • -14.8% Return on Assets means that Allakos generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Allakos Inc:

  • The MRQ is -14.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -24.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.8%TTM-24.4%+9.6%
TTM-24.4%YOY-12.2%-12.2%
TTM-24.4%5Y-15.3%-9.1%
5Y-15.3%10Y-19.0%+3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.8%-11.3%-3.5%
TTM-24.4%-11.8%-12.6%
YOY-12.2%-11.3%-0.9%
5Y-15.3%-12.6%-2.7%
10Y-19.0%-14.2%-4.8%
4.3.1.3. Return on Equity

Shows how efficient Allakos is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • -25.3% Return on Equity means Allakos generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Allakos Inc:

  • The MRQ is -25.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.3%TTM-40.6%+15.4%
TTM-40.6%YOY-15.4%-25.3%
TTM-40.6%5Y-21.0%-19.7%
5Y-21.0%10Y-28.0%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.3%-14.2%-11.1%
TTM-40.6%-15.9%-24.7%
YOY-15.4%-14.4%-1.0%
5Y-21.0%-18.5%-2.5%
10Y-28.0%-19.5%-8.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Allakos Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Allakos is operating .

  • Measures how much profit Allakos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Allakos Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-151.0%+151.0%
TTM-151.0%YOY--151.0%
TTM-151.0%5Y-30.2%-120.8%
5Y-30.2%10Y-18.9%-11.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM-151.0%-313.2%+162.2%
YOY--219.0%+219.0%
5Y-30.2%-388.9%+358.7%
10Y-18.9%-495.6%+476.7%
4.3.2.2. Operating Ratio

Measures how efficient Allakos is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Allakos Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.510-1.510
TTM1.510YOY-+1.510
TTM1.5105Y0.302+1.208
5Y0.30210Y0.189+0.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.340-2.340
TTM1.5103.187-1.677
YOY-3.282-3.282
5Y0.3024.814-4.512
10Y0.1896.494-6.305
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Allakos Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Allakos is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.08 means the company has $6.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Allakos Inc:

  • The MRQ is 6.079. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.668. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.079TTM4.668+1.411
TTM4.668YOY9.861-5.193
TTM4.6685Y14.988-10.320
5Y14.98810Y15.927-0.940
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0793.645+2.434
TTM4.6683.883+0.785
YOY9.8614.666+5.195
5Y14.9885.964+9.024
10Y15.9276.265+9.662
4.4.3.2. Quick Ratio

Measures if Allakos is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • A Quick Ratio of 10.95 means the company can pay off $10.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Allakos Inc:

  • The MRQ is 10.949. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.788. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.949TTM7.788+3.162
TTM7.788YOY14.624-6.836
TTM7.7885Y24.673-16.885
5Y24.67310Y24.830-0.157
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9493.014+7.935
TTM7.7883.418+4.370
YOY14.6244.456+10.168
5Y24.6735.970+18.703
10Y24.8306.424+18.406
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Allakos Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Allakos assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Allakos to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.42 means that Allakos assets are financed with 41.5% credit (debt) and the remaining percentage (100% - 41.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Allakos Inc:

  • The MRQ is 0.415. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.400. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.415TTM0.400+0.016
TTM0.400YOY0.204+0.195
TTM0.4005Y0.198+0.202
5Y0.19810Y0.318-0.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4150.350+0.065
TTM0.4000.341+0.059
YOY0.2040.310-0.106
5Y0.1980.365-0.167
10Y0.3180.382-0.064
4.5.4.2. Debt to Equity Ratio

Measures if Allakos is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Allakos to the Biotechnology industry mean.
  • A Debt to Equity ratio of 71.1% means that company has $0.71 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Allakos Inc:

  • The MRQ is 0.711. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.680. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.711TTM0.680+0.030
TTM0.680YOY0.257+0.423
TTM0.6805Y0.282+0.399
5Y0.28210Y0.297-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7110.394+0.317
TTM0.6800.432+0.248
YOY0.2570.380-0.123
5Y0.2820.451-0.169
10Y0.2970.490-0.193
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Allakos generates.

  • Above 15 is considered overpriced but always compare Allakos to the Biotechnology industry mean.
  • A PE ratio of -0.79 means the investor is paying $-0.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Allakos Inc:

  • The EOD is -1.337. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.794. Based on the earnings, the company is expensive. -2
  • The TTM is -0.750. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.337MRQ-0.794-0.543
MRQ-0.794TTM-0.750-0.044
TTM-0.750YOY-2.651+1.900
TTM-0.7505Y-20.827+20.077
5Y-20.82710Y-23.873+3.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.337-2.315+0.978
MRQ-0.794-2.491+1.697
TTM-0.750-3.156+2.406
YOY-2.651-3.274+0.623
5Y-20.827-6.037-14.790
10Y-23.873-6.785-17.088
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Allakos Inc:

  • The EOD is -0.774. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.460. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.289. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.774MRQ-0.460-0.315
MRQ-0.460TTM-1.289+0.830
TTM-1.289YOY-2.986+1.696
TTM-1.2895Y-26.277+24.987
5Y-26.27710Y-29.175+2.899
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.774-2.985+2.211
MRQ-0.460-3.361+2.901
TTM-1.289-3.734+2.445
YOY-2.986-4.557+1.571
5Y-26.277-8.327-17.950
10Y-29.175-9.311-19.864
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Allakos is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.80 means the investor is paying $0.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Allakos Inc:

  • The EOD is 1.351. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.802. Based on the equity, the company is cheap. +2
  • The TTM is 1.098. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.351MRQ0.802+0.549
MRQ0.802TTM1.098-0.296
TTM1.098YOY1.572-0.473
TTM1.0985Y7.102-6.004
5Y7.10210Y7.769-0.666
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3511.919-0.568
MRQ0.8022.051-1.249
TTM1.0982.374-1.276
YOY1.5722.454-0.882
5Y7.1023.737+3.365
10Y7.7694.378+3.391
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Allakos Inc.

4.8.1. Institutions holding Allakos Inc

Institutions are holding 81.618% of the shares of Allakos Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Bvf Inc18.52670.31631655241700
2024-09-30NEA Management Company, LLC6.88050.2177614726000
2024-09-30FMR Inc6.01080.0002537024768562314.6356
2024-09-30Deep Track Capital, LP5.59640.1036500000000
2024-09-30Vanguard Group Inc3.93350351434500
2024-09-30Redmile Group, LLC3.44490.1184307782800
2024-09-30Vivo Capital, LLC3.30870.15982956110-31890-1.0673
2024-09-30Logos Global Management LP3.24590.20442900000-2900000-50
2024-09-30Opaleye Management Inc2.69480.26232407600-372400-13.3957
2024-09-30Citadel Advisors Llc2.00360.00021790073-716329-28.58
2024-09-30Point72 Asset Management, L.P.1.95870.0029175000017500000
2024-06-30BlackRock Inc1.418301267129-3453642-73.1584
2024-09-30Rock Springs Capital Management LP1.34360.0255120040900
2024-09-30Junked Platinum Investment Management Ltd1.18660.0314106013900
2024-09-30Millennium Management LLC1.12280.00031003149-2419946-70.6947
2024-09-30Morgan Stanley - Brokerage Accounts1.11520.0001996353-2552793-71.927
2024-09-30Geode Capital Management, LLC1.1060.0001988171807638.9004
2024-09-30Ikarian Capital, LLC1.08870.088697267500
2024-06-30Deutsche Bank AG1.02190.0004913039-27772-2.9519
2024-09-30Barclays PLC0.97370.0002869969-264049-23.2844
Total 67.98131.532460736913-10222435-16.8%

4.9.2. Funds holding Allakos Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Advisor Biotechnology I5.4360.1686485670000
2024-10-31Vanguard Total Stock Mkt Idx Inv2.61930.0002234016100
2024-09-30HBM Healthcare Investments AG Ord1.67890.0465150000000
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.13040.0012100995200
2024-10-31Xtrackers S&P Global Infra Swap ETF 1C1.02190.437291297700
2024-09-30Fidelity Extended Market Index0.49580.00074429684535311.4063
2024-11-26Fidelity Enhanced Small Cap ETF0.40890.029436529700
2024-11-27iShares Micro-Cap ETF0.20220.018318063000
2024-08-31Fidelity VIP Disciplined Small Cap Init0.17810.025415908900
2024-09-30Bridgeway Ultra-Small Company Market0.17420.058115560000
2024-09-30BlackRock Extended Equity Market K0.16440.0007146840-62-0.0422
2024-09-30Fidelity Total Market Index0.12820.000111450300
2024-09-30Fidelity Series Total Market Index0.11450.00011023101121512.3113
2024-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.09650.00048620700
2024-09-30Vanguard Instl Ttl Stck Mkt Idx Tr0.09650.00028620700
2024-09-30SG Actions US Techno C0.08470.00757568600
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0830.00077414500
2024-09-30Northern Trust Extended Eq Market Idx0.07890.00067047200
2024-09-30NT Ext Equity Mkt Idx Fd - L0.07890.00067047200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.06690.0007597391820.3056
Total 14.33820.797212809955+56688+0.4%

5.3. Insider Transactions

Insiders are holding 2.315% of the shares of Allakos Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-06-28Harlan Baird RadfordSELL870641.01
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets124,434
Total Liabilities51,691
Total Stockholder Equity72,743
 As reported
Total Liabilities 51,691
Total Stockholder Equity+ 72,743
Total Assets = 124,434

Assets

Total Assets124,434
Total Current Assets97,153
Long-term Assets27,281
Total Current Assets
Cash And Cash Equivalents 10,449
Short-term Investments 82,266
Other Current Assets 4,438
Total Current Assets  (as reported)97,153
Total Current Assets  (calculated)97,153
+/-0
Long-term Assets
Property Plant Equipment 25,613
Long-term Assets Other 1,668
Long-term Assets  (as reported)27,281
Long-term Assets  (calculated)27,281
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities15,981
Long-term Liabilities35,710
Total Stockholder Equity72,743
Total Current Liabilities
Short-term Debt 3,292
Accounts payable 3,964
Other Current Liabilities 8,725
Total Current Liabilities  (as reported)15,981
Total Current Liabilities  (calculated)15,981
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt35,710
Long-term Liabilities  (as reported)35,710
Long-term Liabilities  (calculated)35,710
+/-0
Total Stockholder Equity
Common Stock89
Retained Earnings -1,234,671
Accumulated Other Comprehensive Income 334
Other Stockholders Equity 1,306,991
Total Stockholder Equity (as reported)72,743
Total Stockholder Equity (calculated)72,743
+/-0
Other
Capital Stock89
Cash and Short Term Investments 92,715
Common Stock Shares Outstanding 89,024
Liabilities and Stockholders Equity 124,434
Net Debt 28,553
Net Invested Capital 72,743
Net Working Capital 81,172
Property Plant and Equipment Gross 35,011
Short Long Term Debt Total 39,002



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,176
0
0
0
87,029
79,777
74,225
205,761
191,259
184,509
169,785
535,147
516,894
500,374
474,457
440,504
719,618
683,768
654,947
621,078
534,824
345,783
306,909
418,566
386,420
350,408
319,196
283,495
243,610
177,312
156,458
124,434
124,434156,458177,312243,610283,495319,196350,408386,420418,566306,909345,783534,824621,078654,947683,768719,618440,504474,457500,374516,894535,147169,785184,509191,259205,76174,22579,77787,02900014,176
   > Total Current Assets 
13,566
0
0
0
86,244
77,322
67,133
197,185
181,609
168,699
154,341
520,075
499,870
483,758
458,282
424,767
669,267
628,949
576,058
531,450
451,581
258,167
221,866
339,202
308,843
282,860
251,562
218,279
179,889
147,634
127,926
97,153
97,153127,926147,634179,889218,279251,562282,860308,843339,202221,866258,167451,581531,450576,058628,949669,267424,767458,282483,758499,870520,075154,341168,699181,609197,18567,13377,32286,24400013,566
       Cash And Cash Equivalents 
13,416
0
0
0
85,207
74,600
19,295
51,635
33,660
31,464
36,457
308,805
38,367
135,942
153,898
104,303
207,177
169,989
203,956
274,420
152,822
36,294
82,452
205,290
87,217
93,854
67,381
70,519
66,440
43,060
26,496
10,449
10,44926,49643,06066,44070,51967,38193,85487,217205,29082,45236,294152,822274,420203,956169,989207,177104,303153,898135,94238,367308,80536,45731,46433,66051,63519,29574,60085,20700013,416
       Short-term Investments 
0
0
0
0
0
0
44,851
141,903
145,246
135,724
116,614
208,199
457,534
343,863
301,048
315,452
451,820
445,945
355,739
231,187
271,416
210,407
129,987
120,030
192,569
158,745
153,721
123,389
104,354
96,192
96,625
82,266
82,26696,62596,192104,354123,389153,721158,745192,569120,030129,987210,407271,416231,187355,739445,945451,820315,452301,048343,863457,534208,199116,614135,724145,246141,90344,851000000
       Other Current Assets 
150
0
0
0
1,037
2,722
2,987
3,647
2,703
1,511
1,270
3,071
3,969
3,953
3,336
5,012
10,270
13,015
16,363
25,843
27,343
11,466
9,427
13,882
29,057
29,458
30,460
24,371
9,095
8,382
4,805
4,438
4,4384,8058,3829,09524,37130,46029,45829,05713,8829,42711,46627,34325,84316,36313,01510,2705,0123,3363,9533,9693,0711,2701,5112,7033,6472,9872,7221,037000150
   > Long-term Assets 
0
0
0
0
785
2,455
7,092
8,576
9,650
15,810
15,444
15,072
17,024
16,616
16,175
15,737
50,351
54,819
78,889
89,628
83,243
87,616
85,043
79,364
77,577
67,548
67,634
65,216
63,721
29,678
28,532
27,281
27,28128,53229,67863,72165,21667,63467,54877,57779,36485,04387,61683,24389,62878,88954,81950,35115,73716,17516,61617,02415,07215,44415,8109,6508,5767,0922,4557850000
       Property Plant Equipment 
333
0
0
0
445
401
3,376
7,624
8,848
15,008
14,642
14,270
14,185
13,777
13,336
12,898
48,076
52,544
62,770
77,503
74,807
75,227
73,262
70,679
69,369
62,567
60,935
59,132
57,505
27,941
26,818
25,613
25,61326,81827,94157,50559,13260,93562,56769,36970,67973,26275,22774,80777,50362,77052,54448,07612,89813,33613,77714,18514,27014,64215,0088,8487,6243,376401445000333
       Long-term Assets Other 
0
0
0
0
340
2,054
3,716
952
802
802
802
802
2,839
2,839
2,839
2,839
2,275
2,275
16,119
12,125
8,436
12,389
10,309
7,213
6,736
3,509
5,227
4,612
4,744
265
242
1,668
1,6682422654,7444,6125,2273,5096,7367,21310,30912,3898,43612,12516,1192,2752,2752,8392,8392,8392,8398028028028029523,7162,0543400000
> Total Liabilities 
7,616
0
0
0
145,797
3,441
149,497
9,806
7,265
16,620
17,635
20,721
21,173
22,330
27,454
26,692
65,223
67,714
83,961
96,525
89,348
85,907
84,100
74,387
75,987
69,960
64,218
62,452
74,793
73,329
72,459
51,691
51,69172,45973,32974,79362,45264,21869,96075,98774,38784,10085,90789,34896,52583,96167,71465,22326,69227,45422,33021,17320,72117,63516,6207,2659,806149,4973,441145,7970007,616
   > Total Current Liabilities 
2,535
0
0
0
2,792
3,418
5,010
8,075
5,256
8,232
9,309
12,498
13,061
14,335
19,579
18,940
22,450
22,887
33,998
40,623
40,249
37,552
36,503
27,588
30,038
29,530
24,484
23,450
36,578
35,921
35,880
15,981
15,98135,88035,92136,57823,45024,48429,53030,03827,58836,50337,55240,24940,62333,99822,88722,45018,94019,57914,33513,06112,4989,3098,2325,2568,0755,0103,4182,7920002,535
       Short-term Debt 
4,990
4,990
0
0
0
0
0
0
123
0
273
391
410
430
450
471
492
514
537
560
2,316
2,915
4,145
3,046
3,161
2,937
2,645
2,766
3,250
3,022
3,155
3,292
3,2923,1553,0223,2502,7662,6452,9373,1613,0464,1452,9152,31656053751449247145043041039127301230000004,9904,990
       Short Long Term Debt 
4,990
4,990
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000004,9904,990
       Accounts payable 
1,041
0
0
0
1,703
2,095
1,928
4,333
2,092
3,789
2,966
3,823
5,963
9,062
9,617
7,581
13,960
9,911
15,663
8,808
13,692
9,128
9,865
4,616
4,832
9,101
4,307
915
1,764
15,748
16,119
3,964
3,96416,11915,7481,7649154,3079,1014,8324,6169,8659,12813,6928,80815,6639,91113,9607,5819,6179,0625,9633,8232,9663,7892,0924,3331,9282,0951,7030001,041
       Other Current Liabilities 
1,494
0
0
0
1,089
1,323
3,082
3,742
36
4,443
7
60
90
242
213
368
87
573
3,470
5,135
4,854
25,509
22,493
19,926
22,045
17,492
927
602
31,564
17,151
16,606
8,725
8,72516,60617,15131,56460292717,49222,04519,92622,49325,5094,8545,1353,47057387368213242906074,443363,7423,0821,3231,0890001,494
   > Long-term Liabilities 
0
0
0
0
143,005
23
144,487
1,731
2,009
8,388
8,326
8,223
8,112
7,995
7,875
7,752
42,773
44,827
49,963
55,902
49,099
48,355
47,597
46,799
45,949
40,430
39,734
39,002
38,215
37,408
36,579
35,710
35,71036,57937,40838,21539,00239,73440,43045,94946,79947,59748,35549,09955,90249,96344,82742,7737,7527,8757,9958,1128,2238,3268,3882,0091,731144,48723143,0050000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
273
8,614
410
8,425
8,325
8,223
43,265
45,341
50,500
56,462
51,415
51,270
51,742
49,845
49,110
43,367
39,734
41,768
41,465
40,430
39,734
39,002
39,00239,73440,43041,46541,76839,73443,36749,11049,84551,74251,27051,41556,46250,50045,34143,2658,2238,3258,4254108,6142730000000000
       Warrants
0
0
0
0
0
0
143,019
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000143,019000000
       Long-term Liabilities Other 
0
0
0
0
0
0
1,468
1,731
2,009
8,388
8,326
8,223
8,112
7,995
7,875
7,752
42,773
44,827
49,963
55,902
49,099
48,355
47,597
46,799
45,949
40,430
0
0
0
0
0
0
00000040,43045,94946,79947,59748,35549,09955,90249,96344,82742,7737,7527,8757,9958,1128,2238,3268,3882,0091,7311,468000000
       Deferred Long Term Liability 
0
0
0
0
200
800
2,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000002,6008002000000
> Total Stockholder Equity
6,560
-36,436
0
0
-58,768
76,336
-75,272
195,955
183,994
167,889
152,150
514,426
495,721
478,044
447,003
413,812
654,395
616,054
570,986
524,553
445,476
259,876
222,809
344,179
310,433
280,448
254,978
221,043
168,817
103,983
83,999
72,743
72,74383,999103,983168,817221,043254,978280,448310,433344,179222,809259,876445,476524,553570,986616,054654,395413,812447,003478,044495,721514,426152,150167,889183,994195,955-75,27276,336-58,76800-36,4366,560
   Common Stock
2
0
0
0
3
41
3
42
42
43
43
48
48
48
49
49
53
53
53
54
54
54
54
85
85
86
87
87
88
89
89
89
8989898887878685855454545453535349494848484343424234130002
   Retained Earnings Total Equity000000-975,180-932,776-889,787-858,950-809,847-612,824-518,460-455,731-398,522-342,964-298,686-256,600-217,308-189,484-164,869-143,137-124,065-104,112-89,584-78,436000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-559
0
3
-33
-15
30
114
102
137
2,006
787
167
8
88
32
19
-153
-469
-260
-64
-284
12
-159
-72
50
20
9
334
33492050-72-15912-284-64-260-469-15319328881677872,00613710211430-15-3330-5590000
   Capital Surplus 
0
0
0
0
0
0
3,158
285,530
288,079
291,881
295,130
679,145
685,020
693,298
702,767
712,282
997,298
1,014,435
1,026,632
1,042,940
1,058,399
1,070,138
1,081,965
1,233,945
1,243,408
1,255,530
0
0
0
0
0
0
0000001,255,5301,243,4081,233,9451,081,9651,070,1381,058,3991,042,9401,026,6321,014,435997,298712,282702,767693,298685,020679,145295,130291,881288,079285,5303,158000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
2,362
145,354
-39,888
79,769
288,079
291,881
295,130
679,145
685,020
693,298
702,767
712,282
997,298
1,014,435
1,026,632
1,042,940
1,058,399
1,070,138
1,081,965
1,233,945
1,243,408
1,255,530
1,265,350
1,276,954
1,287,156
1,293,497
1,300,200
1,306,991
1,306,9911,300,2001,293,4971,287,1561,276,9541,265,3501,255,5301,243,4081,233,9451,081,9651,070,1381,058,3991,042,9401,026,6321,014,435997,298712,282702,767693,298685,020679,145295,130291,881288,07979,769-39,888145,3542,3620000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-6,141
Gross Profit-6,141-6,141
 
Operating Income (+$)
Gross Profit-6,141
Operating Expense-196,056
Operating Income-196,056-202,197
 
Operating Expense (+$)
Research Development150,908
Selling General Administrative45,148
Selling And Marketing Expenses45,103
Operating Expense196,056241,159
 
Net Interest Income (+$)
Interest Income10,740
Interest Expense-0
Other Finance Cost-0
Net Interest Income10,740
 
Pretax Income (+$)
Operating Income-196,056
Net Interest Income10,740
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-185,701-206,411
EBIT - interestExpense = -196,056
-185,701
-185,701
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-196,056-185,701
Earnings Before Interest and Taxes (EBITDA)-189,915
 
After tax Income (+$)
Income Before Tax-185,701
Tax Provision-0
Net Income From Continuing Ops-166,139-185,701
Net Income-185,701
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses196,056
Total Other Income/Expenses Net10,355-10,740
 

Technical Analysis of Allakos
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Allakos. The general trend of Allakos is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Allakos's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Allakos Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.555 < 1.69 < 1.72.

The bearish price targets are: 0.8302 > 0.7962 > 0.7255.

Tweet this
Allakos Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Allakos Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Allakos Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Allakos Inc. The current macd is -0.000023.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Allakos price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Allakos. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Allakos price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Allakos Inc Daily Moving Average Convergence/Divergence (MACD) ChartAllakos Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Allakos Inc. The current adx is 32.55.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Allakos shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Allakos Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Allakos Inc. The current sar is 0.84023338.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Allakos Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Allakos Inc. The current rsi is 52.47. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Allakos Inc Daily Relative Strength Index (RSI) ChartAllakos Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Allakos Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Allakos price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Allakos Inc Daily Stochastic Oscillator ChartAllakos Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Allakos Inc. The current cci is -6.60819699.

Allakos Inc Daily Commodity Channel Index (CCI) ChartAllakos Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Allakos Inc. The current cmo is 6.99828526.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Allakos Inc Daily Chande Momentum Oscillator (CMO) ChartAllakos Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Allakos Inc. The current willr is -30.7657247.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Allakos is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Allakos Inc Daily Williams %R ChartAllakos Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Allakos Inc.

Allakos Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Allakos Inc. The current atr is 0.11617197.

Allakos Inc Daily Average True Range (ATR) ChartAllakos Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Allakos Inc. The current obv is -58,050,989.

Allakos Inc Daily On-Balance Volume (OBV) ChartAllakos Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Allakos Inc. The current mfi is 26.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Allakos Inc Daily Money Flow Index (MFI) ChartAllakos Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Allakos Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Allakos Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Allakos Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.475
Ma 20Greater thanMa 501.112
Ma 50Greater thanMa 1000.987
Ma 100Greater thanMa 2000.848
OpenGreater thanClose1.100
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Allakos with someone you think should read this too:
  • Are you bullish or bearish on Allakos? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Allakos? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Allakos Inc

I send you an email if I find something interesting about Allakos Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Allakos Inc.

Receive notifications about Allakos Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.